Beyond maximum grade: A novel method to assess toxicity over time in clinical trials of targeted therapy in lymphoma. The combination of ibrutinib and venetoclax (ABT-199) to achieve complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results